Opioid Overdose

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Deka Biosciences
Deka BiosciencesMD - Germantown
1 program
1
intradermal naloxonePhase 41 trial
Active Trials
NCT05876572WithdrawnEst. Dec 2024

Trial Timeline

Clinical trial activity over time

2024
2025
2026
Deka Biosciencesintradermal naloxone

Clinical Trials (1)

NCT05876572Deka Biosciencesintradermal naloxone

Blood Naloxone Levels Following Intradermal Injection in Humans

Start: Aug 2024Est. completion: Dec 2024
Phase 4Withdrawn

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space